These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14987328)

  • 1. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.
    Barkun AN; Adam V; Sung JJ; Kuipers EJ; Mössner J; Jensen D; Stuart R; Lau JY; Nauclér E; Kilhamn J; Granstedt H; Liljas B; Lind T
    Pharmacoeconomics; 2010; 28(3):217-30. PubMed ID: 20151726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.
    Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M
    Aliment Pharmacol Ther; 2004 Jul; 20(2):195-202. PubMed ID: 15233700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
    Enns RA; Gagnon YM; Rioux KP; Levy AR
    Aliment Pharmacol Ther; 2003 Jan; 17(2):225-33. PubMed ID: 12534407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
    Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA
    Value Health; 2003; 6(4):457-65. PubMed ID: 12859587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness and budget impact of intravenous versus oral proton pump inhibitors in peptic ulcer hemorrhage.
    Spiegel BM; Dulai GS; Lim BS; Mann N; Kanwal F; Gralnek IM
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):988-997. PubMed ID: 16844422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding.
    Al-Sabah S; Barkun AN; Herba K; Adam V; Fallone C; Mayrand S; Pomier-Layrargues G; Kennedy W; Bardou M
    Clin Gastroenterol Hepatol; 2008 Apr; 6(4):418-25. PubMed ID: 18304891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding.
    Erstad BL
    Crit Care Med; 2004 Jun; 32(6):1277-83. PubMed ID: 15187506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic Doppler ultrasound versus endoscopic stigmata-directed management of acute peptic ulcer hemorrhage: a multimodel cost analysis.
    Chen VK; Wong RC
    Dig Dis Sci; 2007 Jan; 52(1):149-60. PubMed ID: 17109216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy.
    Yen HH; Yang CW; Su WW; Soon MS; Wu SS; Lin HJ
    BMC Gastroenterol; 2012 Jun; 12():66. PubMed ID: 22681960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.
    Keating GM
    Pharmacoeconomics; 2011 Jun; 29(6):535-43. PubMed ID: 21568358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing or Dosing of Intravenous Proton Pump Inhibitors in Acute Upper Gastrointestinal Bleeding Has Low Impact on Costs.
    Lu Y; Adam V; Teich V; Barkun A
    Am J Gastroenterol; 2016 Oct; 111(10):1389-1398. PubMed ID: 27140030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.
    Tsoi KK; Lau JY; Sung JJ
    Gastrointest Endosc; 2008 Jun; 67(7):1056-63. PubMed ID: 18407271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.
    Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M
    Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.
    Tseng GY; Fang CT; Lin HJ; Yang HB; Tseng GC; Wang PC; Liao PC; Cheng YT; Huang CH
    Aliment Pharmacol Ther; 2009 Aug; 30(4):406-13. PubMed ID: 19485981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
    Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
    Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of intravenous proton pump inhibitors in high-risk bleeders.
    van Zanten SV
    Can J Gastroenterol; 2004 Dec; 18(12):749-50. PubMed ID: 15605141
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer.
    Lee KK; You JH; Wong IC; Kwong SK; Lau JY; Chan TY; Lau JT; Leung WY; Sung JJ; Chung SS
    Gastrointest Endosc; 2003 Feb; 57(2):160-4. PubMed ID: 12556776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic and laboratory parameters in patientis with peptic ulcer bleeding treated by two modalities of endoscopic haemostasis and proton pump inhibitors.
    Mehmedović-Redzepović A; Mesihović R; Prnjavorac B; Kulo A; Merlina K
    Med Glas (Zenica); 2011 Feb; 8(1):151-7. PubMed ID: 21263414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.